Evidence map›Paper›PMID 33336286›Full record

ArticleIntensive care medicine experimental2020

Liver-lung interactions in acute respiratory distress syndrome.

Raquel Herrero, Gema Sánchez, Iris Asensio, Eva López, Antonio Ferruelo, Javier Vaquero, Laura Moreno, Alba de Lorenzo, Rafael Bañares, José A Lorente

Open access · goldAbstract read
In one paragraph

Article in Intensive care medicine experimental, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Trial
  2. Review
  3. Article
  4. Inter-Organ Communication in Pulmonary Fibrosis: Systemic Modifiers of a Lung-Centered Disease.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Transcriptomic insights intoThe veterinary quarterly · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Hepatic involvement in major respiratory viral infections.Clinical and experimental hepatology · 2025
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Raquel HerreroDepartment of Critical Care Medicine, Hospital Universitario de Getafe, Madrid, Spain. raquelher@hotmail.com.ORCID http://orcid.org/0000-0001-8789-0904
Gema SánchezFundación de Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.
Iris AsensioServicio de Aparato Digestivo. HGU Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Eva LópezFundación de Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.
Antonio FerrueloCIBER de Enfermedades Respiratorias, Instituto de Investigación Carlos III, Madrid, Spain.
Javier VaqueroServicio de Aparato Digestivo. HGU Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Laura MorenoCIBER de Enfermedades Respiratorias, Instituto de Investigación Carlos III, Madrid, Spain.
Alba de LorenzoFundación de Investigación Biomédica del Hospital Universitario de Getafe, Madrid, Spain.
Rafael BañaresServicio de Aparato Digestivo. HGU Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
José A LorenteDepartment of Critical Care Medicine, Hospital Universitario de Getafe, Madrid, Spain.
Hospital Universitario de Getafe · ESHospital General Universitario Gregorio Marañón · ESCentro de Investigación Biomédica en Red · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESUniversidad Complutense de Madrid · ES

Funding

Comunidad de Madrid B2017/BMD-3727-EXOHEP-CMInstituto de Salud Carlos III PI15/01942Instituto de Salud Carlos III PI19/01091, PI15/00482, PI12/02451
6 · The paper itself

Abstract

Patients with liver diseases are at high risk for the development of acute respiratory distress syndrome (ARDS). The liver is an important organ that regulates a complex network of mediators and modulates organ interactions during inflammatory disorders. Liver function is increasingly recognized as a critical determinant of the pathogenesis and resolution of ARDS, significantly influencing the prognosis of these patients. The liver plays a central role in the synthesis of proteins, metabolism of toxins and drugs, and in the modulation of immunity and host defense. However, the tools for assessing liver function are limited in the clinical setting, and patients with liver diseases are frequently excluded from clinical studies of ARDS. Therefore, the mechanisms by which the liver participates in the pathogenesis of acute lung injury are not totally understood. Several functions of the liver, including endotoxin and bacterial clearance, release and clearance of pro-inflammatory cytokines and eicosanoids, and synthesis of acute-phase proteins can modulate lung injury in the setting of sepsis and other severe inflammatory diseases. In this review, we summarized clinical and experimental support for the notion that the liver critically regulates systemic and pulmonary responses following inflammatory insults. Although promoting inflammation can be detrimental in the context of acute lung injury, the liver response to an inflammatory insult is also pro-defense and pro-survival. A better understanding of the liver-lung axis will provide valuable insights into new diagnostic targets and therapeutic strategies for clinical intervention in patients with or at risk for ARDS.

Indexed as

Acute-phase responseAcute respiratory distress syndromeCritical illnessImmunomodulationLiver dysfunctionLiver–lung interactionMechanisms

Identifiers

PMID33336286
PMCPMC7746785
OpenAlexW3115809916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.